Re-timing mortality risk through individualized modelling of lifespan trajectories
Abstract There is an urgent global need for affordable, large-scale health screening to enhance preventive care in the ageing population.
Trained on a European cohort and externally validated across three independent external cohorts spanning Southeast Asia, Eurasia and North America, RetiME showed robust associations with all-cause and cause-specific mortality and predicted the incidence of a wide range of systemic and ocular diseases.
